Human antigen R: Exploring its inflammatory response impact and significance in cardiometabolic disorders
- PMID: 38426269
- DOI: 10.1002/jcp.31229
Human antigen R: Exploring its inflammatory response impact and significance in cardiometabolic disorders
Abstract
RNA-binding proteins (RBPs) play a crucial role in the regulation of posttranscriptional RNA networks, which can undergo dysregulation in many pathological conditions. Human antigen R (HuR) is a highly researched RBP that plays a crucial role as a posttranscriptional regulator. HuR plays a crucial role in the amplification of inflammatory signals by stabilizing the messenger RNA of diverse inflammatory mediators and key molecular players. The noteworthy correlations between HuR and its target molecules, coupled with the remarkable impacts reported on the pathogenesis and advancement of multiple diseases, position HuR as a promising candidate for therapeutic intervention in diverse inflammatory conditions. This review article examines the significance of HuR as a member of the RBP family, its regulatory mechanisms, and its implications in the pathophysiology of inflammation and cardiometabolic illnesses. Our objective is to illuminate potential directions for future research and drug development by conducting a comprehensive analysis of the existing body of research on HuR.
Keywords: HuR; RNA‐binding proteins (RBPs); abnormal vision Drosophila‐like 1 (ELAVL1); cardiometabolic disease; inflammation.
© 2024 The Authors. Journal of Cellular Physiology published by Wiley Periodicals LLC.
Similar articles
-
Posttranscriptional Regulation of the Inflammatory Marker C-Reactive Protein by the RNA-Binding Protein HuR and MicroRNA 637.Mol Cell Biol. 2015 Dec;35(24):4212-21. doi: 10.1128/MCB.00645-15. Epub 2015 Oct 5. Mol Cell Biol. 2015. PMID: 26438598 Free PMC article.
-
HuR as a molecular target for cancer therapeutics and immune-related disorders.Adv Drug Deliv Rev. 2022 Sep;188:114442. doi: 10.1016/j.addr.2022.114442. Epub 2022 Jul 8. Adv Drug Deliv Rev. 2022. PMID: 35817212 Free PMC article. Review.
-
Emerging role of HuR in inflammatory response in kidney diseases.Acta Biochim Biophys Sin (Shanghai). 2017 Sep 1;49(9):753-763. doi: 10.1093/abbs/gmx071. Acta Biochim Biophys Sin (Shanghai). 2017. PMID: 28910975 Review.
-
Understanding and targeting the disease-related RNA binding protein human antigen R (HuR).Wiley Interdiscip Rev RNA. 2020 May;11(3):e1581. doi: 10.1002/wrna.1581. Epub 2020 Jan 23. Wiley Interdiscip Rev RNA. 2020. PMID: 31970930 Free PMC article. Review.
-
The RNA-binding protein HuR in human cancer: A friend or foe?Adv Drug Deliv Rev. 2022 May;184:114179. doi: 10.1016/j.addr.2022.114179. Epub 2022 Mar 3. Adv Drug Deliv Rev. 2022. PMID: 35248670 Free PMC article. Review.
References
REFERENCES
-
- Ahmed, R., Muralidharan, R., Srivastava, A., Johnston, S. E., Zhao, Y. D., Ekmekcioglu, S., Munshi, A., & Ramesh, R. (2021). Molecular targeting of HuR oncoprotein suppresses MITF and induces apoptosis in melanoma cells. Cancers, 13(2), 166. https://doi.org/10.3390/cancers13020166
-
- Al‐Ahmadi, W., Al‐Ghamdi, M., Al‐Haj, L., Al‐Saif, M., & Khabar, K. S. A. (2009). Alternative polyadenylation variants of the RNA binding protein, HuR: Abundance, role of AU‐rich elements and auto‐regulation. Nucleic Acids Research, 37(11), 3612–3624. https://doi.org/10.1093/nar/gkp223
-
- Amadio, M., Bucolo, C., Drago, F., Govoni, S., & Pascale, A. (2009). A new potential pharmacological target in diabetic retinopathy: The HuR pathway. Acta Ophthalmologica, 87(s244). https://doi.org/10.1111/j.1755-3768.2009.219.x
-
- Amadio, M., Bucolo, C., Leggio, G. M., Drago, F., Govoni, S., & Pascale, A. (2010). The PKCβ/HuR/VEGF pathway in diabetic retinopathy. Biochemical Pharmacology, 80(8), 1230–1237. https://doi.org/10.1016/j.bcp.2010.06.033
-
- Amadio, M., Pascale, A., Cupri, S., Pignatello, R., Osera, C., D□Agata, V., D□Amico, A. G., Leggio, G. M., Ruozi, B., Govoni, S., Drago, F., & Bucolo, C. (2016). Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat. Pharmacological Research, 111, 713–720. https://doi.org/10.1016/j.phrs.2016.07.042
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous